Banner - NPPA Connect

Pediatric Dermatology

Latest News



Aruba — Along with improved safety over topical steroids, calcineurin inhibitors appear to offer relief for a variety of skin conditions including pruritus and psoriasis, especially in sensitive areas, according to Joseph F. Fowler, Jr., M.D., clinical professor, University of Louisville"s Division of Dermatology.

New Orleans — Recent headlines underscore the life-threatening dangers of topical medications — information that may shock the lay community. Dermatologists should take into account the well-known risks to internal organ systems that these drugs present, according to Peter J. Aronson, M.D.

MoleMapCD technology from DigitalDerm allows patients and doctors to monitor potentially deadly changes in the skin with accuracy and objectivity, the company says.

The incidence of melanoma is continuing to increase faster than that of any other cancer in the United States, said Darrell S. Rigel, M.D.

Local treatment with the topical immunomodulator tacrolimus 0.1 percent ointment (Protopic, Fujisawa) may be a useful adjunct in the management of pyoderma gangrenosum (PG), and can some times be used successfully as monotherapy, perhaps particularly for the treatment of peristomal disease, said David Fivenson, M.D.

Videodermatoscopy has been demonstrated to have several potential and useful applications in dermatology including parasitoses, hair disorders, as well as other dermatoses, says Giuseppe Micali, M.D.

Palmoplantar pustulosis (palmoplantar pustular psoriasis) presents a frustrating therapeutic challenge to clinicians and a disabling disease for patients deserving of greater research interest from the global dermatology community, says Robert J.G. Chalmers, M.B.B.S.

Dr. Amonette takes gold

Former AAD president, Rex A. Amonette, M.D., received the Gold Metal award, the highest award given by the Academy, yesterday.

Palmoplantar pustulosis (palmoplantar pustular psoriasis) presents a frustrating therapeutic challenge to clinicians and a disabling disease for patients deserving of greater research interest from the global dermatology community, says Robert J.G. Chalmers, M.B.B.S.

As more knowledge is gained into the pathophysiology of atopic eczema, it is important to understand the underlying eliciting factors in the diagnosis and treatment of the condition.

A new approach, cell transfer immunotherapy, can cause regressions in more than half of patients with metastatic melanoma refractory to all other treatments.